학술논문
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
Document Type
Artikel
Author
Source
European journal of nuclear medicine and molecular imaging. 48(12):2121-2139
Subject
Language
English
English
English
ISSN
1619-7089